Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Encourages TB Drug Development But Wary Of Promoting Resistance

Executive Summary

FDA's approach to TB drug development demonstrates the traits Commissioner Margaret Hamburg wants in her agency - transparent, proactive, public health-oriented

You may also be interested in...



Orphan, Tropical Diseases Need Better Drug Development Guidance - Senate

A floor amendment to the Senate Agriculture/FDA appropriations bill would push FDA toward streamlining the development and regulation of drugs to treat rare diseases and neglected diseases in the developing world

Orphan, Tropical Diseases Need Better Drug Development Guidance - Senate

A floor amendment to the Senate Agriculture/FDA appropriations bill would push FDA toward streamlining the development and regulation of drugs to treat rare diseases and neglected diseases in the developing world

FDA Appropriations In Senate: Money For Generics; Worry About Tobacco

Senate appropriators would like to see FDA spend $93 million in fiscal year 2010 on its generic drugs program

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS051192

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel